Annual CFF:
$193.45M-$223.03M(-53.55%)Summary
- As of today, ONC annual cash from financing is $193.45 million, with the most recent change of -$223.03 million (-53.55%) on December 31, 2024.
- During the last 3 years, ONC annual cash from financing has fallen by -$3.44 billion (-94.68%).
- ONC annual cash from financing is now -96.28% below its all-time high of $5.20 billion, reached on December 1, 2020.
Performance
ONC Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFF:
$963.17M+$928.14M(+2649.71%)Summary
- As of today, ONC quarterly cash from financing is $963.17 million, with the most recent change of +$928.14 million (+2649.71%) on September 30, 2025.
- Over the past year, ONC quarterly cash from financing has increased by +$950.51 million (+7506.78%).
- ONC quarterly cash from financing is now -71.58% below its all-time high of $3.39 billion, reached on December 1, 2021.
Performance
ONC Quarterly Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
$959.90M+$950.51M(+10122.46%)Summary
- As of today, ONC TTM cash from financing is $959.90 million, with the most recent change of +$950.51 million (+10122.46%) on September 30, 2025.
- Over the past year, ONC TTM cash from financing has increased by +$414.88 million (+76.12%).
- ONC TTM cash from financing is now -81.65% below its all-time high of $5.23 billion, reached on December 1, 2020.
Performance
ONC TTM Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
ONC Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -53.5% | +7506.8% | +76.1% |
| 3Y3 Years | -94.7% | +701.0% | -72.4% |
| 5Y5 Years | +125.8% | -52.4% | -81.7% |
ONC Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -94.7% | +1119.7% | at high | +972.7% | at high | +2444.9% |
| 5Y | 5-Year | -96.3% | +1119.7% | -71.6% | +972.7% | -81.7% | +2444.9% |
| All-Time | All-Time | -96.3% | +1119.7% | -71.6% | +972.7% | -81.7% | +2444.9% |
ONC Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $963.17M(+2649.7%) | $959.90M(>+9900.0%) |
| Jun 2025 | - | $35.03M(+203.7%) | $9.39M(+458.3%) |
| Mar 2025 | - | -$33.78M(-646.8%) | -$2.62M(-101.4%) |
| Dec 2024 | $193.45M(-53.6%) | -$4.52M(-135.7%) | $193.45M(-64.5%) |
| Sep 2024 | - | $12.66M(-45.0%) | $545.02M(+19.6%) |
| Jun 2024 | - | $23.02M(-85.8%) | $455.58M(-23.9%) |
| Mar 2024 | - | $162.29M(-53.2%) | $598.64M(+43.7%) |
| Dec 2023 | $416.48M(+2295.3%) | $347.05M(+552.0%) | $416.48M(+1117.4%) |
| Sep 2023 | - | -$76.78M(-146.2%) | -$40.94M(-126.2%) |
| Jun 2023 | - | $166.08M(+935.9%) | $156.09M(+666.1%) |
| Mar 2023 | - | -$19.87M(+82.0%) | -$27.57M(-45.3%) |
| Dec 2022 | -$18.97M(-100.5%) | - | - |
| Dec 2022 | - | -$110.37M(-191.8%) | -$18.97M(-100.5%) |
| Sep 2022 | - | $120.24M(+784.0%) | $3.48B(+0.3%) |
| Jun 2022 | - | -$17.58M(-56.0%) | $3.47B(-1.5%) |
| Mar 2022 | - | -$11.27M(-100.3%) | $3.52B(-3.3%) |
| Dec 2021 | $3.64B(-30.1%) | $3.39B(+3003.7%) | $3.64B(+530.2%) |
| Sep 2021 | - | $109.21M(+206.5%) | $577.91M(-76.8%) |
| Jun 2021 | - | $35.63M(-66.8%) | $2.49B(-1.8%) |
| Mar 2021 | - | $107.42M(-67.0%) | $2.54B(-51.5%) |
| Dec 2020 | $5.20B | $325.66M(-83.9%) | $5.23B(+6.6%) |
| Sep 2020 | - | $2.02B(+2397.4%) | $4.91B(+68.6%) |
| Jun 2020 | - | $80.99M(-97.1%) | $2.91B(+2.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | $2.80B(>+9900.0%) | $2.84B(+3378.1%) |
| Dec 2019 | $85.68M(-94.9%) | $2.20M(-91.3%) | $81.68M(-7.5%) |
| Sep 2019 | - | $25.14M(+120.8%) | $88.28M(-90.6%) |
| Jun 2019 | - | $11.38M(-73.5%) | $934.40M(-3.6%) |
| Mar 2019 | - | $42.96M(+388.1%) | $969.60M(-42.6%) |
| Dec 2018 | $1.69B(+244.8%) | $8.80M(-99.0%) | $1.69B(+0.3%) |
| Sep 2018 | - | $871.25M(+1770.3%) | $1.68B(+46.1%) |
| Jun 2018 | - | $46.58M(-93.9%) | $1.15B(-6.8%) |
| Mar 2018 | - | $763.90M(>+9900.0%) | $1.24B(+160.0%) |
| Dec 2017 | $490.36M(+28.7%) | $3.05M(-99.1%) | $475.83M(-29.1%) |
| Sep 2017 | - | $339.71M(+160.2%) | $671.47M(+97.8%) |
| Jun 2017 | - | $130.54M(+5053.6%) | $339.40M(+59.1%) |
| Mar 2017 | - | $2.53M(-98.7%) | $213.39M(-44.0%) |
| Dec 2016 | $380.90M(+269.1%) | $198.69M(+2500.7%) | $380.90M(+109.2%) |
| Sep 2016 | - | $7.64M(+69.0%) | $182.09M(+0.7%) |
| Jun 2016 | - | $4.52M(-97.3%) | $180.82M(-33.8%) |
| Mar 2016 | - | $170.05M(>+9900.0%) | $273.25M(+164.8%) |
| Dec 2015 | $103.20M(+97.8%) | -$119.00K(-101.9%) | $103.20M(-0.1%) |
| Sep 2015 | - | $6.37M(-93.4%) | $103.32M(+6.6%) |
| Jun 2015 | - | $96.95M(>+9900.0%) | $96.95M(>+9900.0%) |
| Mar 2015 | - | $0.00 | $0.00 |
| Dec 2014 | $52.16M(>+9900.0%) | - | - |
| Dec 2013 | -$482.00K | - | - |
FAQ
- What is BeOne Medicines Ltd. annual cash from financing?
- What is the all-time high annual cash from financing for BeOne Medicines Ltd.?
- What is BeOne Medicines Ltd. annual cash from financing year-on-year change?
- What is BeOne Medicines Ltd. quarterly cash from financing?
- What is the all-time high quarterly cash from financing for BeOne Medicines Ltd.?
- What is BeOne Medicines Ltd. quarterly cash from financing year-on-year change?
- What is BeOne Medicines Ltd. TTM cash from financing?
- What is the all-time high TTM cash from financing for BeOne Medicines Ltd.?
- What is BeOne Medicines Ltd. TTM cash from financing year-on-year change?
What is BeOne Medicines Ltd. annual cash from financing?
The current annual cash from financing of ONC is $193.45M
What is the all-time high annual cash from financing for BeOne Medicines Ltd.?
BeOne Medicines Ltd. all-time high annual cash from financing is $5.20B
What is BeOne Medicines Ltd. annual cash from financing year-on-year change?
Over the past year, ONC annual cash from financing has changed by -$223.03M (-53.55%)
What is BeOne Medicines Ltd. quarterly cash from financing?
The current quarterly cash from financing of ONC is $963.17M
What is the all-time high quarterly cash from financing for BeOne Medicines Ltd.?
BeOne Medicines Ltd. all-time high quarterly cash from financing is $3.39B
What is BeOne Medicines Ltd. quarterly cash from financing year-on-year change?
Over the past year, ONC quarterly cash from financing has changed by +$950.51M (+7506.78%)
What is BeOne Medicines Ltd. TTM cash from financing?
The current TTM cash from financing of ONC is $959.90M
What is the all-time high TTM cash from financing for BeOne Medicines Ltd.?
BeOne Medicines Ltd. all-time high TTM cash from financing is $5.23B
What is BeOne Medicines Ltd. TTM cash from financing year-on-year change?
Over the past year, ONC TTM cash from financing has changed by +$414.88M (+76.12%)